Glycemic fluctuations caused by COVID-19: Results from continuous glucose monitoring
| Autor: | Jian Zhou, Lei Zhang, Yun Shen, Xiaohong Fan |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Endocrinology Diabetes and Metabolism Short Communication 030209 endocrinology & metabolism Gastroenterology Impaired glucose tolerance 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Internal medicine Internal Medicine Medicine Glycemic Potential impact 030109 nutrition & dietetics business.industry Continuous glucose monitoring Significant difference Public Health Environmental and Occupational Health COVID-19 Glycemic fluctuation Glucose tolerance medicine.disease Postprandial business |
| Zdroj: | Obesity Medicine |
| ISSN: | 2451-8476 |
| Popis: | Aim We aimed to address the potential impact of COVID-19 on glycemic patterns in a small pilot study. Method 13 patients with mild COVID-19 who were confirmed without diabetes and another group of 18 healthy individuals with available CGM data were well matched and enrolled into the final analysis. Results We noticed significantly higher TARs of >140 mg/dL (median 13.9% vs. 2.3%, P = 0.006), >160 mg/dL (median 4.7% vs. 0.0%, P = 0.011) and >180 mg/dL (median 1.9% vs. 0.0%, P = 0.007) among non-diabetic patients with COVID-19 than those among healthy individuals. There was no significant difference in TBR of 0.1). Consequently, the TIR of 70 mg/dL to 140 mg/dL was significantly lower in non-diabetic patients with COVID-19 than that in healthy individuals (median 80.1% vs. 93.1%, P = 0.001). Significant postprandial glycemic fluctuations were observed among patients with COVID-19. There was a remarkable difference in CV in non-diabetic patients with COVID-19 compared to healthy individuals (median 25.6% vs. 15.7%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect